David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Public Health Ethics 3 (2):178-185 (2010)
Is it really necessary to add something like the Health Impact Fund to the existing global patent system? We can divide this question into two parts. First, is there something seriously wrong with the status quo and, if so, what exactly is it? Second, how do we best go about solving the problem; that is, how does the design of the reform proposal address the flaws in the status quo? Jorn Sonderholm, in his critique of the Health Impact Fund, or HIF, raises both of these issues. These criticisms afford us the opportunity to reaffirm our commitment to ameliorating glaring problems with the current system for incentivizing R&D for essential medicines, and to clarify why we believe the HIF is exactly what the world needs
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Thomas W. Pogge (2005). Human Rights and Global Health: A Research Program. Metaphilosophy 36 (1‐2):182-209.
Jorn Sonderholm (2009). Wild-Card Patent Extensions as a Means to Incentivize Research and Development of Antibiotics. Journal of Law, Medicine and Ethics 37 (2):240-246.
Jorn Sonderholm (2009). Wild-Card Patent Extensions as a Means to Incentivize Research and Development of Antibiotics. Journal of Law, Medicine & Ethics 37 (2):240-246.
Jorn Sonderholm (2009). In Defence of Priority Review Vouchers. Bioethics 23 (7):413-420.
Citations of this work BETA
Jorn Sonderholm (2010). Ethical Issues Surrounding Intellectual Property Rights. Philosophy Compass 5 (12):1107-1115.
Tom Andreassen (2015). Patent Funded Access to Medicines. Developing World Bioethics 15 (3):152-161.
Ross Upshur, Ian Kerridge, Wendy Lipworth, Christopher Mayes & Chris Degeling (2015). The Political and Ethical Challenge of Multi-Drug Resistant Tuberculosis. Journal of Bioethical Inquiry 12 (1):107-113.
Similar books and articles
Leo Strauss (2011). Hobbes's Critique of Religion and Related Writings. The University of Chicago Press.
Gert J. J. Biesta & Geert Jan J. M. Stams (2001). Critical Thinking and the Question of Critique: Some Lessons From Deconstruction. Studies in Philosophy and Education 20 (1):57-74.
Vincent Descombes (1988). A Propos of the “Critique of the Subject” and of the Critique of This Critique. Topoi 7 (2):123-131.
Y. S. Lo (2001). The Land Ethic and Callicott's Ethical System (1980-2001): An Overview and Critique. Inquiry 44 (3):331 – 358.
Alberto Toscano (2011). Against Speculation, or, a Critique of the Critique of Critique: A Remark on Quentin Meillassoux's After Finitude (After Colletti). In Levi R. Bryant, Nick Srnicek & Graham Harman (eds.), The Speculative Turn: Continental Materialism and Realism. Re.Press
Ville Päivänsalo (2009). Responsibilities for Global Health: The Efficiency of the Health Impact Fund? Public Health Ethics 2 (1):100-104.
William Desmond (2005). Is There Metaphysics After Critique? International Philosophical Quarterly 45 (2):221-241.
Aidan Hollis (2008). The Health Impact Fund: A Useful Supplement to the Patent System? Public Health Ethics 1 (2):124-133.
Michael Ravvin (2008). Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions. Public Health Ethics 1 (2):110-123.
Added to index2010-08-11
Total downloads20 ( #142,353 of 1,726,249 )
Recent downloads (6 months)1 ( #369,877 of 1,726,249 )
How can I increase my downloads?